Company Summary
Search
Home Page
 
Quest PharmaTech Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
January 31TradingN
Board of Directors
NamePosition
Bin Huang  Director of the Board
Ian McConnan  Director of the Board
Lorne T. Meikle  Director of the Board
Madi Ragupathy Madiyalakan  Director of the Board
Not Applicable (None)  President
Paul Van Damme  Director of the Board
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
16/Dec/1996  Canada Alberta ALBERTA - 12/16/96 
Exchange Filing Office
Location
Calgary Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Research and Development of Pharmaceutical Products  News Release November 10, 2014-Quest PharmaTech is a publicly traded, Canadian based clinical stage company developing a portfolio of product candidates for the treatment of cancer by combining immunotherapeutic antibodies with chemotherapy, immune-adjuvants and photodynamic therapy. Quest has a body of clinical experience and a new appreciation of the obstacles and potential of combinatorial immunotherapeutic approaches to cancer by using either immunoglobulin G or E as immune modulators to enhance tumor specific immunity and clinical outcome. 
Securities
SymbolSecurity NameMarketStatus
QPTQuest Pharmatech Inc.TSX VentureTRADING
Name HistoryFromTo
Quest PharmaTech Inc.5/Oct/2005Present
Company Facts Reconciliation
SubjectDate Returned
Fall 2014 CFRNot Received
Associations
Auditing Firm:  Ernst & Young, Chartered Accountants
Law Firm:  Miller Thomson LLP
Subsidiary:  Steroidogenesis Inhibitors Canada Inc.
  Sonolight Pharmaceuticals Corp.
  Danamedix Inc.
  Altachem Pharma Inc.
Transfer Agent:  Computershare Trust Company of Canada
Latest Information
TypeDateTitle
News Releases  10/Nov/2014  NEWS RELEASE - QUEST PHARMATECH ANNOUNCES RESULTS FROM ITS 2014 AGM[CANADA NEWSWIRE]
    NEWS RELEASE - QUEST PHARMATECH TO MARKET AND DISTRIBUTE PREMIUM ANTI-WRINKLE SKIN CARE PRODUCT BELLUS SKIN(TM); DR. JACQUELINE SHAN CREATOR OF COLD FX® TO ASSIST[CANADA NEWSWIRE]
    NEWS RELEASE - QUEST PHARMATECH SIGNS LICENSE AGREEMENT WITH BIOCELTRAN CO. LTD. FOR PHOTODYNAMIC THERAPY TECHNOLOGY[MARKETWIRE]
Bulletins  29/Sep/2014  PP-N-B
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data